Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.
Press releases published on October 3, 2025
October 3, 2025
PanTerra and Five9 Announce Webinar on Transforming Healthcare Communications with AI
Indeterminate
EIN Presswire
October 3, 2025
Vaziri Law Group Highlights the Hidden Costs of Pedestrian Accidents in California
Indeterminate
EIN Presswire
October 3, 2025
Eysz, Inc. Awarded NIH SBIR Fast-Track Grant to expand into Remote Monitoring of Childhood Absence Epilepsy
Indeterminate
EIN Presswire
October 3, 2025
Laser Clinique becomes the first office to offer the newest FDA approve technology called XERF™
Indeterminate
EIN Presswire
October 3, 2025
Montclair Plaza Dental Group Announces Name Change to Double A Dental Group
Indeterminate
EIN Presswire
October 3, 2025
Contemporary Care Introduces TMS Therapy to Naples, Florida
Indeterminate
GlobeNewswire
October 3, 2025
New Book by 2Mynds Offers a Game-Changing Blueprint for Routine Building in Sports and Corporate Life
Indeterminate
EIN Presswire
October 3, 2025
Publication relating to transparency notifications
Indeterminate
GlobeNewswire
October 3, 2025
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 3, 2025
Publication relative à des notifications de transparence
Indeterminate
GlobeNewswire
October 3, 2025
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 3, 2025
Spyre Therapeutics Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
October 3, 2025
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 3, 2025
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 3, 2025
argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025
Indeterminate
GlobeNewswire
October 3, 2025
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 3, 2025
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 3, 2025
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 3, 2025
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 3, 2025
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire